Please login to the form below

Not currently logged in
Email:
Password:

Duodopa

This page shows the latest Duodopa news and features for those working in and with pharma, biotech and healthcare.

SMC approves Amgen orphan drug for use in NHS Scotland

SMC approves Amgen orphan drug for use in NHS Scotland

Also accepts AbbVie's former orphan drug Duodopa, but rejects Sanofi's Jevtana.  . ... The health technology assessment body also approved AbbVie's drug/device combination Duodopa (co-careldopa) for advanced Parkinson's disease.

Latest news

  • AbbVie sales jump on strong Humira gains AbbVie sales jump on strong Humira gains

    and Duodopa. ... Non-US sales of drug-device combination Duodopa for Parkinson's disease grew around 25 per cent to $44m, and AbbVie said it remains hopeful of approval for the product in

  • Chasing the cure for Parkinson's disease Chasing the cure for Parkinson's disease

    AbbVie (formerly Abbott Laboratories) is developing an intraduodenal gel formulation of levodopa/carbidopa (LGIC; Duodopa) for the treatment of late-stage Parkinson's in patients who have failed conventional oral levodopa

  • R&D news in brief

    ìSLV308 is for less advanced stages of Parkinson's disease, while the recently acquired drug Duodopa is intended for people suffering from late-stages of the disease so there are good

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

Stick or Twist? Healthcare brands in a (post) COVID-19 world
...
Stick or twist? Looking at the patient experience as we emerge from the COVID pandemic
...
Lockdown entertainment or healthcare revolution? The role of video games in healthcare
...